Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(ADAMTS13). Showing records 1 – 30 of 31 total matches.

[1] [2]

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters

1. Hori, Yuji; Hayakawa, Masaki; Isonishi, Ayami; Soejima, Kenji; Matsumoto, Masanori. ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: Implications for selection of plasma preparations for TTP treatment : クリオ上清中の高分子VWFマルチマー非結合型ADAMTS13の存在:血栓性血小板減少性紫斑病の治療に、より効果的な血漿分画製剤の選択.

Degree: 博士(医学), 2013, Nara Medical University / 奈良県立医科大学

BACKGROUND: Thrombotic thrombocytopenic purpura (TTP) is characterized by deficient ADAMTS13 activity. Treatment involves plasma exchange (PE). Both fresh-frozen plasma (FFP) and cryosupernatant (CSP) are used,… (more)

Subjects/Keywords: IEF; VWF-ADAMTS13 complex; VWF; ADAMTS13

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hori, Yuji; Hayakawa, Masaki; Isonishi, Ayami; Soejima, Kenji; Matsumoto, M. (2013). ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: Implications for selection of plasma preparations for TTP treatment : クリオ上清中の高分子VWFマルチマー非結合型ADAMTS13の存在:血栓性血小板減少性紫斑病の治療に、より効果的な血漿分画製剤の選択. (Thesis). Nara Medical University / 奈良県立医科大学. Retrieved from http://hdl.handle.net/10564/2677

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hori, Yuji; Hayakawa, Masaki; Isonishi, Ayami; Soejima, Kenji; Matsumoto, Masanori. “ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: Implications for selection of plasma preparations for TTP treatment : クリオ上清中の高分子VWFマルチマー非結合型ADAMTS13の存在:血栓性血小板減少性紫斑病の治療に、より効果的な血漿分画製剤の選択.” 2013. Thesis, Nara Medical University / 奈良県立医科大学. Accessed December 05, 2020. http://hdl.handle.net/10564/2677.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hori, Yuji; Hayakawa, Masaki; Isonishi, Ayami; Soejima, Kenji; Matsumoto, Masanori. “ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: Implications for selection of plasma preparations for TTP treatment : クリオ上清中の高分子VWFマルチマー非結合型ADAMTS13の存在:血栓性血小板減少性紫斑病の治療に、より効果的な血漿分画製剤の選択.” 2013. Web. 05 Dec 2020.

Vancouver:

Hori, Yuji; Hayakawa, Masaki; Isonishi, Ayami; Soejima, Kenji; Matsumoto M. ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: Implications for selection of plasma preparations for TTP treatment : クリオ上清中の高分子VWFマルチマー非結合型ADAMTS13の存在:血栓性血小板減少性紫斑病の治療に、より効果的な血漿分画製剤の選択. [Internet] [Thesis]. Nara Medical University / 奈良県立医科大学; 2013. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/10564/2677.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hori, Yuji; Hayakawa, Masaki; Isonishi, Ayami; Soejima, Kenji; Matsumoto M. ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: Implications for selection of plasma preparations for TTP treatment : クリオ上清中の高分子VWFマルチマー非結合型ADAMTS13の存在:血栓性血小板減少性紫斑病の治療に、より効果的な血漿分画製剤の選択. [Thesis]. Nara Medical University / 奈良県立医科大学; 2013. Available from: http://hdl.handle.net/10564/2677

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

2. Joly, Bérangère. Déficit fonctionnel sévère en ADAMTS13 (protéase spécifique de clivage du facteur Willebrand) : physiopathologie du purpura thrombotique thrombocytopénique de l’enfant : Severe functional deficiency of ADAMTS13 (von Willebrand factor-cleaving protease) : pathophysiology of child-onset thrombotic thrombocytopenic purpura.

Degree: Docteur es, Médecine. Hématologie, 2018, Sorbonne Paris Cité

Le purpura thrombotique thrombocytopénique (PTT) est défini par un déficit sévère en ADAMTS13, la protéase de clivage du facteur Willebrand (VWF). Physiologiquement, ADAMTS13 adopte une… (more)

Subjects/Keywords: Anticorps anti-ADAMTS13; Anti-ADAMTS13 antibodies

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Joly, B. (2018). Déficit fonctionnel sévère en ADAMTS13 (protéase spécifique de clivage du facteur Willebrand) : physiopathologie du purpura thrombotique thrombocytopénique de l’enfant : Severe functional deficiency of ADAMTS13 (von Willebrand factor-cleaving protease) : pathophysiology of child-onset thrombotic thrombocytopenic purpura. (Doctoral Dissertation). Sorbonne Paris Cité. Retrieved from http://www.theses.fr/2018USPCC252

Chicago Manual of Style (16th Edition):

Joly, Bérangère. “Déficit fonctionnel sévère en ADAMTS13 (protéase spécifique de clivage du facteur Willebrand) : physiopathologie du purpura thrombotique thrombocytopénique de l’enfant : Severe functional deficiency of ADAMTS13 (von Willebrand factor-cleaving protease) : pathophysiology of child-onset thrombotic thrombocytopenic purpura.” 2018. Doctoral Dissertation, Sorbonne Paris Cité. Accessed December 05, 2020. http://www.theses.fr/2018USPCC252.

MLA Handbook (7th Edition):

Joly, Bérangère. “Déficit fonctionnel sévère en ADAMTS13 (protéase spécifique de clivage du facteur Willebrand) : physiopathologie du purpura thrombotique thrombocytopénique de l’enfant : Severe functional deficiency of ADAMTS13 (von Willebrand factor-cleaving protease) : pathophysiology of child-onset thrombotic thrombocytopenic purpura.” 2018. Web. 05 Dec 2020.

Vancouver:

Joly B. Déficit fonctionnel sévère en ADAMTS13 (protéase spécifique de clivage du facteur Willebrand) : physiopathologie du purpura thrombotique thrombocytopénique de l’enfant : Severe functional deficiency of ADAMTS13 (von Willebrand factor-cleaving protease) : pathophysiology of child-onset thrombotic thrombocytopenic purpura. [Internet] [Doctoral dissertation]. Sorbonne Paris Cité; 2018. [cited 2020 Dec 05]. Available from: http://www.theses.fr/2018USPCC252.

Council of Science Editors:

Joly B. Déficit fonctionnel sévère en ADAMTS13 (protéase spécifique de clivage du facteur Willebrand) : physiopathologie du purpura thrombotique thrombocytopénique de l’enfant : Severe functional deficiency of ADAMTS13 (von Willebrand factor-cleaving protease) : pathophysiology of child-onset thrombotic thrombocytopenic purpura. [Doctoral Dissertation]. Sorbonne Paris Cité; 2018. Available from: http://www.theses.fr/2018USPCC252


Johannes Gutenberg Universität Mainz

3. Falter, Tanja. Untersuchungen über ADAMTS13 in Gerinnungsfaktorpräparaten.

Degree: 2011, Johannes Gutenberg Universität Mainz

 Zusammenfassung rnIn der vorliegenden Arbeit wurden sechs VWF/FVIII Gerinnungsfaktorkonzentrate unterschiedlicher Chargen auf ihre ADAMTS13 Aktivität, Antigen und VWF Multimere untersucht. Grund dafür ist die Annahme,… (more)

Subjects/Keywords: ADAMTS13; TTP; VWF; Gerinnungsfaktorkonzentrate; ADAMTS13; TTP; VWF; Natural sciences and mathematics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Falter, T. (2011). Untersuchungen über ADAMTS13 in Gerinnungsfaktorpräparaten. (Doctoral Dissertation). Johannes Gutenberg Universität Mainz. Retrieved from http://ubm.opus.hbz-nrw.de/volltexte/2011/2816/

Chicago Manual of Style (16th Edition):

Falter, Tanja. “Untersuchungen über ADAMTS13 in Gerinnungsfaktorpräparaten.” 2011. Doctoral Dissertation, Johannes Gutenberg Universität Mainz. Accessed December 05, 2020. http://ubm.opus.hbz-nrw.de/volltexte/2011/2816/.

MLA Handbook (7th Edition):

Falter, Tanja. “Untersuchungen über ADAMTS13 in Gerinnungsfaktorpräparaten.” 2011. Web. 05 Dec 2020.

Vancouver:

Falter T. Untersuchungen über ADAMTS13 in Gerinnungsfaktorpräparaten. [Internet] [Doctoral dissertation]. Johannes Gutenberg Universität Mainz; 2011. [cited 2020 Dec 05]. Available from: http://ubm.opus.hbz-nrw.de/volltexte/2011/2816/.

Council of Science Editors:

Falter T. Untersuchungen über ADAMTS13 in Gerinnungsfaktorpräparaten. [Doctoral Dissertation]. Johannes Gutenberg Universität Mainz; 2011. Available from: http://ubm.opus.hbz-nrw.de/volltexte/2011/2816/


Johannes Gutenberg Universität Mainz

4. John, Marie-Luise Bärbel. Untersuchungen zur autoimmunen Genese der thrombotisch thrombozytopenischen Purpura.

Degree: 2012, Johannes Gutenberg Universität Mainz

 Untersuchungen zur autoimmunen Genese der thrombotisch thrombozytopenischen Purpura. rnEinführung: Die idiopathische thrombotisch thrombozytopenische Purpura (TTP) ist eine lebensbedrohliche Mikroangiopathie und wird durch ein Autoantikörper-induziertes Defizit… (more)

Subjects/Keywords: TTP; HLA; Autoimmunität; ADAMTS13; Genetische Prädisposition; TTP; HLA; Autoimmunity; ADAMTS13; Genetic susceptibility; Medical sciences Medicine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

John, M. B. (2012). Untersuchungen zur autoimmunen Genese der thrombotisch thrombozytopenischen Purpura. (Doctoral Dissertation). Johannes Gutenberg Universität Mainz. Retrieved from http://ubm.opus.hbz-nrw.de/volltexte/2013/3386/

Chicago Manual of Style (16th Edition):

John, Marie-Luise Bärbel. “Untersuchungen zur autoimmunen Genese der thrombotisch thrombozytopenischen Purpura.” 2012. Doctoral Dissertation, Johannes Gutenberg Universität Mainz. Accessed December 05, 2020. http://ubm.opus.hbz-nrw.de/volltexte/2013/3386/.

MLA Handbook (7th Edition):

John, Marie-Luise Bärbel. “Untersuchungen zur autoimmunen Genese der thrombotisch thrombozytopenischen Purpura.” 2012. Web. 05 Dec 2020.

Vancouver:

John MB. Untersuchungen zur autoimmunen Genese der thrombotisch thrombozytopenischen Purpura. [Internet] [Doctoral dissertation]. Johannes Gutenberg Universität Mainz; 2012. [cited 2020 Dec 05]. Available from: http://ubm.opus.hbz-nrw.de/volltexte/2013/3386/.

Council of Science Editors:

John MB. Untersuchungen zur autoimmunen Genese der thrombotisch thrombozytopenischen Purpura. [Doctoral Dissertation]. Johannes Gutenberg Universität Mainz; 2012. Available from: http://ubm.opus.hbz-nrw.de/volltexte/2013/3386/

5. Gilardin, Laurent. Identification des épitopes T d’ADAMTS13 chez les patients atteints de Purpura Thrombotique Thrombocytopénique : ADAMTS13 T cell epitope identification in ThromboticThrombocytopenic Purpura patients.

Degree: Docteur es, Sciences de la vie et de la santé, 2019, Université Paris-Saclay (ComUE)

Le purpura thrombotique thrombocytopénique (PTT) est une maladie autoimmune rare et grave caractérisée par la présence d’anticorps dirigés contre ADAMTS13 (A13), une protéase impliquée dans… (more)

Subjects/Keywords: Épitope T; ADAMTS13; Purpura; PTT; MAT; T-Cell epitope; TTP; Purpura; ADAMTS13; TMA

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gilardin, L. (2019). Identification des épitopes T d’ADAMTS13 chez les patients atteints de Purpura Thrombotique Thrombocytopénique : ADAMTS13 T cell epitope identification in ThromboticThrombocytopenic Purpura patients. (Doctoral Dissertation). Université Paris-Saclay (ComUE). Retrieved from http://www.theses.fr/2019SACLS520

Chicago Manual of Style (16th Edition):

Gilardin, Laurent. “Identification des épitopes T d’ADAMTS13 chez les patients atteints de Purpura Thrombotique Thrombocytopénique : ADAMTS13 T cell epitope identification in ThromboticThrombocytopenic Purpura patients.” 2019. Doctoral Dissertation, Université Paris-Saclay (ComUE). Accessed December 05, 2020. http://www.theses.fr/2019SACLS520.

MLA Handbook (7th Edition):

Gilardin, Laurent. “Identification des épitopes T d’ADAMTS13 chez les patients atteints de Purpura Thrombotique Thrombocytopénique : ADAMTS13 T cell epitope identification in ThromboticThrombocytopenic Purpura patients.” 2019. Web. 05 Dec 2020.

Vancouver:

Gilardin L. Identification des épitopes T d’ADAMTS13 chez les patients atteints de Purpura Thrombotique Thrombocytopénique : ADAMTS13 T cell epitope identification in ThromboticThrombocytopenic Purpura patients. [Internet] [Doctoral dissertation]. Université Paris-Saclay (ComUE); 2019. [cited 2020 Dec 05]. Available from: http://www.theses.fr/2019SACLS520.

Council of Science Editors:

Gilardin L. Identification des épitopes T d’ADAMTS13 chez les patients atteints de Purpura Thrombotique Thrombocytopénique : ADAMTS13 T cell epitope identification in ThromboticThrombocytopenic Purpura patients. [Doctoral Dissertation]. Université Paris-Saclay (ComUE); 2019. Available from: http://www.theses.fr/2019SACLS520

6. Fukushima, Hidetada; Nishio, Kenji; Asai, Hideki; Watanabe, Tomoo; Seki, Tadahiko; Matsui, Hideto; Sugimoto, Mitsuhiko; Matsumoto, Masanori; Fujimura, Yoshihiro. Ratio of von Willebrand factor propeptide to ADAMTS13 is associated with severity of sepsis.

Degree: 博士(医学), 2013, Nara Medical University / 奈良県立医科大学

Von Willebrand factor (VWF)-cleaving protease (ADAMTS13) cleaves ultralarge VWF (ULVWF) secreted from endothelium and by which is regulating its physiologic function. An imbalance between ULVWF… (more)

Subjects/Keywords: sepsis; von Willebrand factor propeptide; ADAMTS13; multiple organ dysfunction

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fukushima, Hidetada; Nishio, Kenji; Asai, Hideki; Watanabe, Tomoo; Seki, Tadahiko; Matsui, Hideto; Sugimoto, Mitsuhiko; Matsumoto, Masanori; Fujimura, Y. (2013). Ratio of von Willebrand factor propeptide to ADAMTS13 is associated with severity of sepsis. (Thesis). Nara Medical University / 奈良県立医科大学. Retrieved from http://hdl.handle.net/10564/2640

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Fukushima, Hidetada; Nishio, Kenji; Asai, Hideki; Watanabe, Tomoo; Seki, Tadahiko; Matsui, Hideto; Sugimoto, Mitsuhiko; Matsumoto, Masanori; Fujimura, Yoshihiro. “Ratio of von Willebrand factor propeptide to ADAMTS13 is associated with severity of sepsis.” 2013. Thesis, Nara Medical University / 奈良県立医科大学. Accessed December 05, 2020. http://hdl.handle.net/10564/2640.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Fukushima, Hidetada; Nishio, Kenji; Asai, Hideki; Watanabe, Tomoo; Seki, Tadahiko; Matsui, Hideto; Sugimoto, Mitsuhiko; Matsumoto, Masanori; Fujimura, Yoshihiro. “Ratio of von Willebrand factor propeptide to ADAMTS13 is associated with severity of sepsis.” 2013. Web. 05 Dec 2020.

Vancouver:

Fukushima, Hidetada; Nishio, Kenji; Asai, Hideki; Watanabe, Tomoo; Seki, Tadahiko; Matsui, Hideto; Sugimoto, Mitsuhiko; Matsumoto, Masanori; Fujimura Y. Ratio of von Willebrand factor propeptide to ADAMTS13 is associated with severity of sepsis. [Internet] [Thesis]. Nara Medical University / 奈良県立医科大学; 2013. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/10564/2640.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Fukushima, Hidetada; Nishio, Kenji; Asai, Hideki; Watanabe, Tomoo; Seki, Tadahiko; Matsui, Hideto; Sugimoto, Mitsuhiko; Matsumoto, Masanori; Fujimura Y. Ratio of von Willebrand factor propeptide to ADAMTS13 is associated with severity of sepsis. [Thesis]. Nara Medical University / 奈良県立医科大学; 2013. Available from: http://hdl.handle.net/10564/2640

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

7. Yamashita, Keigo; Yagi, Hideo; Hayakawa, Masaki; Abe, Takehisa; Hayata, Yoshihiro; Yamaguchi, Naoko; Sugimoto, Mitsuhiko; Fujimura, Yoshihiro; Matsumoto, Masanori. Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve Replacement. : 重度大動脈弁狭窄症患者の大動脈弁置換術後における血小板機能および高分子量 von Willebrand 因子多量体の急速な回復.

Degree: 博士(医学), 2017, Nara Medical University / 奈良県立医科大学

AIM: Patients with severe aortic stenosis (AS) may have bleeding episodes due to the loss of high-molecular-weight (HMW) von Willebrand factor multimers (VWFMs). The absence… (more)

Subjects/Keywords: Aortic valve stenosis; Acquired von Willebrand syndrome; Thrombus formation; ADAMTS13

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yamashita, Keigo; Yagi, Hideo; Hayakawa, Masaki; Abe, Takehisa; Hayata, Yoshihiro; Yamaguchi, Naoko; Sugimoto, Mitsuhiko; Fujimura, Yoshihiro; Matsumoto, M. (2017). Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve Replacement. : 重度大動脈弁狭窄症患者の大動脈弁置換術後における血小板機能および高分子量 von Willebrand 因子多量体の急速な回復. (Thesis). Nara Medical University / 奈良県立医科大学. Retrieved from http://hdl.handle.net/10564/3328

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Yamashita, Keigo; Yagi, Hideo; Hayakawa, Masaki; Abe, Takehisa; Hayata, Yoshihiro; Yamaguchi, Naoko; Sugimoto, Mitsuhiko; Fujimura, Yoshihiro; Matsumoto, Masanori. “Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve Replacement. : 重度大動脈弁狭窄症患者の大動脈弁置換術後における血小板機能および高分子量 von Willebrand 因子多量体の急速な回復.” 2017. Thesis, Nara Medical University / 奈良県立医科大学. Accessed December 05, 2020. http://hdl.handle.net/10564/3328.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Yamashita, Keigo; Yagi, Hideo; Hayakawa, Masaki; Abe, Takehisa; Hayata, Yoshihiro; Yamaguchi, Naoko; Sugimoto, Mitsuhiko; Fujimura, Yoshihiro; Matsumoto, Masanori. “Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve Replacement. : 重度大動脈弁狭窄症患者の大動脈弁置換術後における血小板機能および高分子量 von Willebrand 因子多量体の急速な回復.” 2017. Web. 05 Dec 2020.

Vancouver:

Yamashita, Keigo; Yagi, Hideo; Hayakawa, Masaki; Abe, Takehisa; Hayata, Yoshihiro; Yamaguchi, Naoko; Sugimoto, Mitsuhiko; Fujimura, Yoshihiro; Matsumoto M. Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve Replacement. : 重度大動脈弁狭窄症患者の大動脈弁置換術後における血小板機能および高分子量 von Willebrand 因子多量体の急速な回復. [Internet] [Thesis]. Nara Medical University / 奈良県立医科大学; 2017. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/10564/3328.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Yamashita, Keigo; Yagi, Hideo; Hayakawa, Masaki; Abe, Takehisa; Hayata, Yoshihiro; Yamaguchi, Naoko; Sugimoto, Mitsuhiko; Fujimura, Yoshihiro; Matsumoto M. Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve Replacement. : 重度大動脈弁狭窄症患者の大動脈弁置換術後における血小板機能および高分子量 von Willebrand 因子多量体の急速な回復. [Thesis]. Nara Medical University / 奈良県立医科大学; 2017. Available from: http://hdl.handle.net/10564/3328

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Cambridge

8. Newnham, Michael. A genome-wide association study in chronic thromboembolic pulmonary hypertension and the ADAMTS13-VWF axis.

Degree: PhD, 2019, University of Cambridge

 Chronic thromboembolic pulmonary hypertension (CTEPH) is an important and severe consequence of pulmonary embolism (PE), resulting from failure of thrombus resolution. Identifying genetic risk factors… (more)

Subjects/Keywords: chronic thromboembolic pulmonary hypertension; ADAMTS13-VWF; genome-wide association study

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Newnham, M. (2019). A genome-wide association study in chronic thromboembolic pulmonary hypertension and the ADAMTS13-VWF axis. (Doctoral Dissertation). University of Cambridge. Retrieved from https://www.repository.cam.ac.uk/handle/1810/308943

Chicago Manual of Style (16th Edition):

Newnham, Michael. “A genome-wide association study in chronic thromboembolic pulmonary hypertension and the ADAMTS13-VWF axis.” 2019. Doctoral Dissertation, University of Cambridge. Accessed December 05, 2020. https://www.repository.cam.ac.uk/handle/1810/308943.

MLA Handbook (7th Edition):

Newnham, Michael. “A genome-wide association study in chronic thromboembolic pulmonary hypertension and the ADAMTS13-VWF axis.” 2019. Web. 05 Dec 2020.

Vancouver:

Newnham M. A genome-wide association study in chronic thromboembolic pulmonary hypertension and the ADAMTS13-VWF axis. [Internet] [Doctoral dissertation]. University of Cambridge; 2019. [cited 2020 Dec 05]. Available from: https://www.repository.cam.ac.uk/handle/1810/308943.

Council of Science Editors:

Newnham M. A genome-wide association study in chronic thromboembolic pulmonary hypertension and the ADAMTS13-VWF axis. [Doctoral Dissertation]. University of Cambridge; 2019. Available from: https://www.repository.cam.ac.uk/handle/1810/308943


University of Lund

9. Tati, Ramesh. Studies of ADAMTS13 expression and activity in the kidney.

Degree: 2013, University of Lund

 Von Willebrand factor (VWF) is an abundant plasma glycoprotein involved in platelet adhesion and aggregation at sites of vascular injury. ADAMTS13 is the sole physiological… (more)

Subjects/Keywords: Pediatrics; ADAMTS13; von WIllebrand factor; thrombotic thrombocytopenic purpura

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tati, R. (2013). Studies of ADAMTS13 expression and activity in the kidney. (Doctoral Dissertation). University of Lund. Retrieved from https://lup.lub.lu.se/record/3469750 ; https://portal.research.lu.se/ws/files/4071236/3469751.pdf

Chicago Manual of Style (16th Edition):

Tati, Ramesh. “Studies of ADAMTS13 expression and activity in the kidney.” 2013. Doctoral Dissertation, University of Lund. Accessed December 05, 2020. https://lup.lub.lu.se/record/3469750 ; https://portal.research.lu.se/ws/files/4071236/3469751.pdf.

MLA Handbook (7th Edition):

Tati, Ramesh. “Studies of ADAMTS13 expression and activity in the kidney.” 2013. Web. 05 Dec 2020.

Vancouver:

Tati R. Studies of ADAMTS13 expression and activity in the kidney. [Internet] [Doctoral dissertation]. University of Lund; 2013. [cited 2020 Dec 05]. Available from: https://lup.lub.lu.se/record/3469750 ; https://portal.research.lu.se/ws/files/4071236/3469751.pdf.

Council of Science Editors:

Tati R. Studies of ADAMTS13 expression and activity in the kidney. [Doctoral Dissertation]. University of Lund; 2013. Available from: https://lup.lub.lu.se/record/3469750 ; https://portal.research.lu.se/ws/files/4071236/3469751.pdf


University of Cambridge

10. Newnham, Michael. A genome-wide association study in chronic thromboembolic pulmonary hypertension and the ADAMTS13-VWF axis.

Degree: PhD, 2019, University of Cambridge

 Chronic thromboembolic pulmonary hypertension (CTEPH) is an important and severe consequence of pulmonary embolism (PE), resulting from failure of thrombus resolution. Identifying genetic risk factors… (more)

Subjects/Keywords: chronic thromboembolic pulmonary hypertension; ADAMTS13-VWF; genome-wide association study

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Newnham, M. (2019). A genome-wide association study in chronic thromboembolic pulmonary hypertension and the ADAMTS13-VWF axis. (Doctoral Dissertation). University of Cambridge. Retrieved from https://doi.org/10.17863/CAM.56034 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.814482

Chicago Manual of Style (16th Edition):

Newnham, Michael. “A genome-wide association study in chronic thromboembolic pulmonary hypertension and the ADAMTS13-VWF axis.” 2019. Doctoral Dissertation, University of Cambridge. Accessed December 05, 2020. https://doi.org/10.17863/CAM.56034 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.814482.

MLA Handbook (7th Edition):

Newnham, Michael. “A genome-wide association study in chronic thromboembolic pulmonary hypertension and the ADAMTS13-VWF axis.” 2019. Web. 05 Dec 2020.

Vancouver:

Newnham M. A genome-wide association study in chronic thromboembolic pulmonary hypertension and the ADAMTS13-VWF axis. [Internet] [Doctoral dissertation]. University of Cambridge; 2019. [cited 2020 Dec 05]. Available from: https://doi.org/10.17863/CAM.56034 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.814482.

Council of Science Editors:

Newnham M. A genome-wide association study in chronic thromboembolic pulmonary hypertension and the ADAMTS13-VWF axis. [Doctoral Dissertation]. University of Cambridge; 2019. Available from: https://doi.org/10.17863/CAM.56034 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.814482


Johannes Gutenberg Universität Mainz

11. Steinemann, Sarah. Untersuchungen zur Plasmapheresetherapie bei Patienten mit thrombotisch thrombozytopenischer Purpura.

Degree: 2012, Johannes Gutenberg Universität Mainz

 Die thrombotische thrombozytopenische Purpura (TTP) ist charakterisiert durch eine Triade aus Thrombozytopenie, hämolytischer Anämie und Mikrothromben. Ursächlich für diese Mikroangiopathie ist ein Mangel der Von… (more)

Subjects/Keywords: Thrombotisch thrombozytopenische Purpura, ADAMTS13, Fresh Frozen Plasma, solvent/detergent Plasma; Thrombotisch thrombozytopenische Purpura, ADAMTS13, Fresh Frozen Plasma, solvent/detergent Plasma; Medical sciences Medicine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Steinemann, S. (2012). Untersuchungen zur Plasmapheresetherapie bei Patienten mit thrombotisch thrombozytopenischer Purpura. (Doctoral Dissertation). Johannes Gutenberg Universität Mainz. Retrieved from http://ubm.opus.hbz-nrw.de/volltexte/2013/3379/

Chicago Manual of Style (16th Edition):

Steinemann, Sarah. “Untersuchungen zur Plasmapheresetherapie bei Patienten mit thrombotisch thrombozytopenischer Purpura.” 2012. Doctoral Dissertation, Johannes Gutenberg Universität Mainz. Accessed December 05, 2020. http://ubm.opus.hbz-nrw.de/volltexte/2013/3379/.

MLA Handbook (7th Edition):

Steinemann, Sarah. “Untersuchungen zur Plasmapheresetherapie bei Patienten mit thrombotisch thrombozytopenischer Purpura.” 2012. Web. 05 Dec 2020.

Vancouver:

Steinemann S. Untersuchungen zur Plasmapheresetherapie bei Patienten mit thrombotisch thrombozytopenischer Purpura. [Internet] [Doctoral dissertation]. Johannes Gutenberg Universität Mainz; 2012. [cited 2020 Dec 05]. Available from: http://ubm.opus.hbz-nrw.de/volltexte/2013/3379/.

Council of Science Editors:

Steinemann S. Untersuchungen zur Plasmapheresetherapie bei Patienten mit thrombotisch thrombozytopenischer Purpura. [Doctoral Dissertation]. Johannes Gutenberg Universität Mainz; 2012. Available from: http://ubm.opus.hbz-nrw.de/volltexte/2013/3379/


Universiteit Utrecht

12. Pos, W. Characterization of human antibodies against ADAMTS13 that develop in patients with acquired TTP.

Degree: 2010, Universiteit Utrecht

 Thrombotic thrombocytopenic purpura (TTP) is a thrombotic micro-angiopathy characterized by the absence or dysfunction of the von Willebrand factor cleaving protease ADAMTS13. Functional absence of… (more)

Subjects/Keywords: Farmacie; Medical technology; Farmacie(FARM); Biomedische technologie en medicijnen; Pharmacology; autoantibodies; ADAMTS13; epitope; TTP; VWF

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pos, W. (2010). Characterization of human antibodies against ADAMTS13 that develop in patients with acquired TTP. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/183095

Chicago Manual of Style (16th Edition):

Pos, W. “Characterization of human antibodies against ADAMTS13 that develop in patients with acquired TTP.” 2010. Doctoral Dissertation, Universiteit Utrecht. Accessed December 05, 2020. http://dspace.library.uu.nl:8080/handle/1874/183095.

MLA Handbook (7th Edition):

Pos, W. “Characterization of human antibodies against ADAMTS13 that develop in patients with acquired TTP.” 2010. Web. 05 Dec 2020.

Vancouver:

Pos W. Characterization of human antibodies against ADAMTS13 that develop in patients with acquired TTP. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2010. [cited 2020 Dec 05]. Available from: http://dspace.library.uu.nl:8080/handle/1874/183095.

Council of Science Editors:

Pos W. Characterization of human antibodies against ADAMTS13 that develop in patients with acquired TTP. [Doctoral Dissertation]. Universiteit Utrecht; 2010. Available from: http://dspace.library.uu.nl:8080/handle/1874/183095


Queens University

13. Pruss, Cynthia Marie. The Influence of Sequence Variation on von Willebrand Factor Biosynthesis, Proteolytic Processing and Clearance .

Degree: Pathology and Molecular Medicine, 2012, Queens University

 Von Willebrand factor (VWF) promotes platelet adhesion and aggregation at sites of vascular damage. This function is directly related to the multimer size of VWF.… (more)

Subjects/Keywords: von Willebrand Factor ; ADAMTS13 ; Hemostasis ; Thrombosis ; von Willebrand Disease ; Bleeding ; Clotting ; Pathology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pruss, C. M. (2012). The Influence of Sequence Variation on von Willebrand Factor Biosynthesis, Proteolytic Processing and Clearance . (Thesis). Queens University. Retrieved from http://hdl.handle.net/1974/7345

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Pruss, Cynthia Marie. “The Influence of Sequence Variation on von Willebrand Factor Biosynthesis, Proteolytic Processing and Clearance .” 2012. Thesis, Queens University. Accessed December 05, 2020. http://hdl.handle.net/1974/7345.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Pruss, Cynthia Marie. “The Influence of Sequence Variation on von Willebrand Factor Biosynthesis, Proteolytic Processing and Clearance .” 2012. Web. 05 Dec 2020.

Vancouver:

Pruss CM. The Influence of Sequence Variation on von Willebrand Factor Biosynthesis, Proteolytic Processing and Clearance . [Internet] [Thesis]. Queens University; 2012. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/1974/7345.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Pruss CM. The Influence of Sequence Variation on von Willebrand Factor Biosynthesis, Proteolytic Processing and Clearance . [Thesis]. Queens University; 2012. Available from: http://hdl.handle.net/1974/7345

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Pennsylvania

14. Skipwith, Christopher Gemil. Regulation of Adamts13 Function in Hemostasis by Cofactor and Substrate Exosite interactions.

Degree: 2012, University of Pennsylvania

ADAMTS13 (A Disintegrin And Metalloprotease with ThromboSpondin type1 repeats-13) is an enzyme that is mainly synthesized in the liver and secreted into the blood stream.… (more)

Subjects/Keywords: ADAMTS13; Factor VIII; Thrombosis; TTP; von Willebrand Disease; von Willebrand Factor; Biochemistry; Biophysics; Pathology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Skipwith, C. G. (2012). Regulation of Adamts13 Function in Hemostasis by Cofactor and Substrate Exosite interactions. (Thesis). University of Pennsylvania. Retrieved from https://repository.upenn.edu/edissertations/701

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Skipwith, Christopher Gemil. “Regulation of Adamts13 Function in Hemostasis by Cofactor and Substrate Exosite interactions.” 2012. Thesis, University of Pennsylvania. Accessed December 05, 2020. https://repository.upenn.edu/edissertations/701.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Skipwith, Christopher Gemil. “Regulation of Adamts13 Function in Hemostasis by Cofactor and Substrate Exosite interactions.” 2012. Web. 05 Dec 2020.

Vancouver:

Skipwith CG. Regulation of Adamts13 Function in Hemostasis by Cofactor and Substrate Exosite interactions. [Internet] [Thesis]. University of Pennsylvania; 2012. [cited 2020 Dec 05]. Available from: https://repository.upenn.edu/edissertations/701.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Skipwith CG. Regulation of Adamts13 Function in Hemostasis by Cofactor and Substrate Exosite interactions. [Thesis]. University of Pennsylvania; 2012. Available from: https://repository.upenn.edu/edissertations/701

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

15. MURPHY, STEPHEN. Profiles of von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in patients with carotid stenosis and their relationship with cerebral micro-embolic signal status.

Degree: School of Medicine. Discipline of Clinical Medicine, 2020, Trinity College Dublin

 Aims: The aims of this thesis were to comprehensively investigate the profiles of von Willebrand Factor (VWF:Ag), von Willebrand Factor propeptide (VWFpp) and A Disintegrin… (more)

Subjects/Keywords: von Willebrand factor antigen; von Willebrand factor propeptide; ADAMTS13 activity; Transcranial Doppler ultrasound; Carotid stenosis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

MURPHY, S. (2020). Profiles of von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in patients with carotid stenosis and their relationship with cerebral micro-embolic signal status. (Thesis). Trinity College Dublin. Retrieved from http://hdl.handle.net/2262/92456

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

MURPHY, STEPHEN. “Profiles of von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in patients with carotid stenosis and their relationship with cerebral micro-embolic signal status.” 2020. Thesis, Trinity College Dublin. Accessed December 05, 2020. http://hdl.handle.net/2262/92456.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

MURPHY, STEPHEN. “Profiles of von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in patients with carotid stenosis and their relationship with cerebral micro-embolic signal status.” 2020. Web. 05 Dec 2020.

Vancouver:

MURPHY S. Profiles of von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in patients with carotid stenosis and their relationship with cerebral micro-embolic signal status. [Internet] [Thesis]. Trinity College Dublin; 2020. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/2262/92456.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

MURPHY S. Profiles of von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in patients with carotid stenosis and their relationship with cerebral micro-embolic signal status. [Thesis]. Trinity College Dublin; 2020. Available from: http://hdl.handle.net/2262/92456

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

16. Takaya, Hiroaki; Uemura, Masahito; Fujimura, Yoshihiro; Matsumoto, Masanori; Matsuyama, Tomomi; Kato, Seiji; Morioka, Chie; Ishizashi, Hiromichi; Hori, Yuji; Fujimoto, Masao; Tsujimoto, Tatsuhiro; Kawaratani, Hideto; Toyohara, Masahisa; Kurumatani, Norio. ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score. : 血漿ADAMTSは肝硬変患者の予後をChild-PughスコアやMELDスコアと同様に生存率を予測できる可能性がある.

Degree: 博士(医学), 2014, Nara Medical University / 奈良県立医科大学

Aim:  Decreased plasma ADAMTS13 activity (ADAMTS13:AC) results in accumulation of unusually large von Willebrand factor multimers and platelet thrombi formation. Our aim was to evaluate… (more)

Subjects/Keywords: ADAMTS13 activity; Child-Turcotte-Pugh score; liver cirrhosis; Model for End-Stage Liver Disease score; prognosis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Takaya, Hiroaki; Uemura, Masahito; Fujimura, Yoshihiro; Matsumoto, Masanori; Matsuyama, Tomomi; Kato, Seiji; Morioka, Chie; Ishizashi, Hiromichi; Hori, Yuji; Fujimoto, Masao; Tsujimoto, Tatsuhiro; Kawaratani, Hideto; Toyohara, Masahisa; Kurumatani, N. (2014). ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score. : 血漿ADAMTSは肝硬変患者の予後をChild-PughスコアやMELDスコアと同様に生存率を予測できる可能性がある. (Thesis). Nara Medical University / 奈良県立医科大学. Retrieved from http://hdl.handle.net/10564/2698

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Takaya, Hiroaki; Uemura, Masahito; Fujimura, Yoshihiro; Matsumoto, Masanori; Matsuyama, Tomomi; Kato, Seiji; Morioka, Chie; Ishizashi, Hiromichi; Hori, Yuji; Fujimoto, Masao; Tsujimoto, Tatsuhiro; Kawaratani, Hideto; Toyohara, Masahisa; Kurumatani, Norio. “ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score. : 血漿ADAMTSは肝硬変患者の予後をChild-PughスコアやMELDスコアと同様に生存率を予測できる可能性がある.” 2014. Thesis, Nara Medical University / 奈良県立医科大学. Accessed December 05, 2020. http://hdl.handle.net/10564/2698.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Takaya, Hiroaki; Uemura, Masahito; Fujimura, Yoshihiro; Matsumoto, Masanori; Matsuyama, Tomomi; Kato, Seiji; Morioka, Chie; Ishizashi, Hiromichi; Hori, Yuji; Fujimoto, Masao; Tsujimoto, Tatsuhiro; Kawaratani, Hideto; Toyohara, Masahisa; Kurumatani, Norio. “ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score. : 血漿ADAMTSは肝硬変患者の予後をChild-PughスコアやMELDスコアと同様に生存率を予測できる可能性がある.” 2014. Web. 05 Dec 2020.

Vancouver:

Takaya, Hiroaki; Uemura, Masahito; Fujimura, Yoshihiro; Matsumoto, Masanori; Matsuyama, Tomomi; Kato, Seiji; Morioka, Chie; Ishizashi, Hiromichi; Hori, Yuji; Fujimoto, Masao; Tsujimoto, Tatsuhiro; Kawaratani, Hideto; Toyohara, Masahisa; Kurumatani N. ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score. : 血漿ADAMTSは肝硬変患者の予後をChild-PughスコアやMELDスコアと同様に生存率を予測できる可能性がある. [Internet] [Thesis]. Nara Medical University / 奈良県立医科大学; 2014. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/10564/2698.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Takaya, Hiroaki; Uemura, Masahito; Fujimura, Yoshihiro; Matsumoto, Masanori; Matsuyama, Tomomi; Kato, Seiji; Morioka, Chie; Ishizashi, Hiromichi; Hori, Yuji; Fujimoto, Masao; Tsujimoto, Tatsuhiro; Kawaratani, Hideto; Toyohara, Masahisa; Kurumatani N. ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score. : 血漿ADAMTSは肝硬変患者の予後をChild-PughスコアやMELDスコアと同様に生存率を予測できる可能性がある. [Thesis]. Nara Medical University / 奈良県立医科大学; 2014. Available from: http://hdl.handle.net/10564/2698

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

17. Koyama, Noriko; Matsumoto, Masanori; Tamaki, Shinji; Yoshikawa, Masanori; Fujimura, Yoshihiro. Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect severity of apnoeic episodes. : 閉塞型睡眠時無呼吸症候群患者における早朝の高分子量フォンウィルブランド因子減少は無呼吸の重症度を反映する.

Degree: Nara Medical University / 奈良県立医科大学

Plasma von Willebrand factor (VWF), produced in and released from vascular endothelial cells by various stimuli including hypoxia, induces platelet aggregation under high shear stress… (more)

Subjects/Keywords: ADAMTS13; obstructive sleep apnoea; von Willebrand factor

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Koyama, Noriko; Matsumoto, Masanori; Tamaki, Shinji; Yoshikawa, Masanori; Fujimura, Y. (n.d.). Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect severity of apnoeic episodes. : 閉塞型睡眠時無呼吸症候群患者における早朝の高分子量フォンウィルブランド因子減少は無呼吸の重症度を反映する. (Thesis). Nara Medical University / 奈良県立医科大学. Retrieved from http://hdl.handle.net/10564/2766

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Koyama, Noriko; Matsumoto, Masanori; Tamaki, Shinji; Yoshikawa, Masanori; Fujimura, Yoshihiro. “Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect severity of apnoeic episodes. : 閉塞型睡眠時無呼吸症候群患者における早朝の高分子量フォンウィルブランド因子減少は無呼吸の重症度を反映する.” Thesis, Nara Medical University / 奈良県立医科大学. Accessed December 05, 2020. http://hdl.handle.net/10564/2766.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Koyama, Noriko; Matsumoto, Masanori; Tamaki, Shinji; Yoshikawa, Masanori; Fujimura, Yoshihiro. “Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect severity of apnoeic episodes. : 閉塞型睡眠時無呼吸症候群患者における早朝の高分子量フォンウィルブランド因子減少は無呼吸の重症度を反映する.” Web. 05 Dec 2020.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Koyama, Noriko; Matsumoto, Masanori; Tamaki, Shinji; Yoshikawa, Masanori; Fujimura Y. Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect severity of apnoeic episodes. : 閉塞型睡眠時無呼吸症候群患者における早朝の高分子量フォンウィルブランド因子減少は無呼吸の重症度を反映する. [Internet] [Thesis]. Nara Medical University / 奈良県立医科大学; [cited 2020 Dec 05]. Available from: http://hdl.handle.net/10564/2766.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Koyama, Noriko; Matsumoto, Masanori; Tamaki, Shinji; Yoshikawa, Masanori; Fujimura Y. Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect severity of apnoeic episodes. : 閉塞型睡眠時無呼吸症候群患者における早朝の高分子量フォンウィルブランド因子減少は無呼吸の重症度を反映する. [Thesis]. Nara Medical University / 奈良県立医科大学; Available from: http://hdl.handle.net/10564/2766

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

18. I. Mancini. ADAMTS13-RELATED ASSAYS IN ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA.

Degree: 2013, Università degli Studi di Milano

 Thrombotic thrombocytopenic purpura (TTP) is a rare but life-threatening microangiopathic disorder, due to the persistence of highly thrombogenic ultra large (UL) von Willebrand factor (VWF)… (more)

Subjects/Keywords: THROMBOTIC THROMBOCYTOPENIC PURPURA; ADAMTS13; ASSAYS; Settore BIO/12 - Biochimica Clinica e Biologia Molecolare Clinica; Settore MED/15 - Malattie del Sangue

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mancini, I. (2013). ADAMTS13-RELATED ASSAYS IN ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA. (Thesis). Università degli Studi di Milano. Retrieved from http://hdl.handle.net/2434/217173

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Mancini, I.. “ADAMTS13-RELATED ASSAYS IN ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA.” 2013. Thesis, Università degli Studi di Milano. Accessed December 05, 2020. http://hdl.handle.net/2434/217173.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Mancini, I.. “ADAMTS13-RELATED ASSAYS IN ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA.” 2013. Web. 05 Dec 2020.

Vancouver:

Mancini I. ADAMTS13-RELATED ASSAYS IN ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA. [Internet] [Thesis]. Università degli Studi di Milano; 2013. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/2434/217173.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Mancini I. ADAMTS13-RELATED ASSAYS IN ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA. [Thesis]. Università degli Studi di Milano; 2013. Available from: http://hdl.handle.net/2434/217173

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

19. Buselli, Monica. Determination of ADAMTS13 Susceptibility in Type IIA von Willebrand Disease.

Degree: MS, Biological Sciences, 2018, Dominican University of California

  von Willebrand Disease (vWD) is a bleeding disorder caused by a deficiency in von Willebrand Factor (vWF), a large glycoprotein that assists in coagulation.… (more)

Subjects/Keywords: Protein characterization; Proteomics; von Willebrand Factor; FPLC; digestion assay; ADAMTS13; Bioinformatics; Biology; Cellular and Molecular Physiology; Molecular Biology; Molecular Genetics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Buselli, M. (2018). Determination of ADAMTS13 Susceptibility in Type IIA von Willebrand Disease. (Masters Thesis). Dominican University of California. Retrieved from https://scholar.dominican.edu/masters-theses/340

Chicago Manual of Style (16th Edition):

Buselli, Monica. “Determination of ADAMTS13 Susceptibility in Type IIA von Willebrand Disease.” 2018. Masters Thesis, Dominican University of California. Accessed December 05, 2020. https://scholar.dominican.edu/masters-theses/340.

MLA Handbook (7th Edition):

Buselli, Monica. “Determination of ADAMTS13 Susceptibility in Type IIA von Willebrand Disease.” 2018. Web. 05 Dec 2020.

Vancouver:

Buselli M. Determination of ADAMTS13 Susceptibility in Type IIA von Willebrand Disease. [Internet] [Masters thesis]. Dominican University of California; 2018. [cited 2020 Dec 05]. Available from: https://scholar.dominican.edu/masters-theses/340.

Council of Science Editors:

Buselli M. Determination of ADAMTS13 Susceptibility in Type IIA von Willebrand Disease. [Masters Thesis]. Dominican University of California; 2018. Available from: https://scholar.dominican.edu/masters-theses/340


University of Gothenburg / Göteborgs Universitet

20. Hanson, Ellen. The hemostatic pathway in ischemic stroke. Clinical studies of genetic variation and plasma protein measurements.

Degree: 2012, University of Gothenburg / Göteborgs Universitet

 Although stroke is a common cause of death and disability in adults, there are few studies on stroke compared to other common diseases. A stroke… (more)

Subjects/Keywords: ischemic stroke; etiologic subtypes of ischemic stroke; genetics; SNP; hemostasis; prothrombotic; ADAMTS13; VWF; ABO blood group; FSAP; FXI

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hanson, E. (2012). The hemostatic pathway in ischemic stroke. Clinical studies of genetic variation and plasma protein measurements. (Thesis). University of Gothenburg / Göteborgs Universitet. Retrieved from http://hdl.handle.net/2077/29210

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hanson, Ellen. “The hemostatic pathway in ischemic stroke. Clinical studies of genetic variation and plasma protein measurements.” 2012. Thesis, University of Gothenburg / Göteborgs Universitet. Accessed December 05, 2020. http://hdl.handle.net/2077/29210.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hanson, Ellen. “The hemostatic pathway in ischemic stroke. Clinical studies of genetic variation and plasma protein measurements.” 2012. Web. 05 Dec 2020.

Vancouver:

Hanson E. The hemostatic pathway in ischemic stroke. Clinical studies of genetic variation and plasma protein measurements. [Internet] [Thesis]. University of Gothenburg / Göteborgs Universitet; 2012. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/2077/29210.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hanson E. The hemostatic pathway in ischemic stroke. Clinical studies of genetic variation and plasma protein measurements. [Thesis]. University of Gothenburg / Göteborgs Universitet; 2012. Available from: http://hdl.handle.net/2077/29210

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Erasmus University Rotterdam

21. Sonneveld, Michelle. Von Willebrand Factor and ADAMTS13 in Cardiovascular Disease.

Degree: Department of Hematology, 2016, Erasmus University Rotterdam

 markdownabstractVon Willebrand Factor plays an important role in primary hemostasis by platelet adhesion and aggregation. High molecular weight VWF multimers are the most procoagulant forms… (more)

Subjects/Keywords: Von Willebrand Factor; ADAMTS13; cardiovascular disease; stroke

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sonneveld, M. (2016). Von Willebrand Factor and ADAMTS13 in Cardiovascular Disease. (Doctoral Dissertation). Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/93807

Chicago Manual of Style (16th Edition):

Sonneveld, Michelle. “Von Willebrand Factor and ADAMTS13 in Cardiovascular Disease.” 2016. Doctoral Dissertation, Erasmus University Rotterdam. Accessed December 05, 2020. http://hdl.handle.net/1765/93807.

MLA Handbook (7th Edition):

Sonneveld, Michelle. “Von Willebrand Factor and ADAMTS13 in Cardiovascular Disease.” 2016. Web. 05 Dec 2020.

Vancouver:

Sonneveld M. Von Willebrand Factor and ADAMTS13 in Cardiovascular Disease. [Internet] [Doctoral dissertation]. Erasmus University Rotterdam; 2016. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/1765/93807.

Council of Science Editors:

Sonneveld M. Von Willebrand Factor and ADAMTS13 in Cardiovascular Disease. [Doctoral Dissertation]. Erasmus University Rotterdam; 2016. Available from: http://hdl.handle.net/1765/93807

22. SMITH, DEIRDRE ROSE. Profiles of von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in patients with ischaemic cerebrovascular disease after commencing or changing antiplatelet therapy.

Degree: School of Medicine. Discipline of Clinical Medicine, 2020, Trinity College Dublin

 Background: There are very limited data on the impact of commonly-prescribed antiplatelet regimens on von Willebrand Factor antigen (VWF:Ag), von Willebrand Factor propeptide (VWFpp) and… (more)

Subjects/Keywords: ischaemic stroke; transient ischaemic attack; von Willebrand factor; ADAMTS13; antiplatelet therapy; endothelial activation; platelet function; high on-treatment platelet reactivity HTPR

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

SMITH, D. R. (2020). Profiles of von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in patients with ischaemic cerebrovascular disease after commencing or changing antiplatelet therapy. (Thesis). Trinity College Dublin. Retrieved from http://hdl.handle.net/2262/93211

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

SMITH, DEIRDRE ROSE. “Profiles of von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in patients with ischaemic cerebrovascular disease after commencing or changing antiplatelet therapy.” 2020. Thesis, Trinity College Dublin. Accessed December 05, 2020. http://hdl.handle.net/2262/93211.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

SMITH, DEIRDRE ROSE. “Profiles of von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in patients with ischaemic cerebrovascular disease after commencing or changing antiplatelet therapy.” 2020. Web. 05 Dec 2020.

Vancouver:

SMITH DR. Profiles of von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in patients with ischaemic cerebrovascular disease after commencing or changing antiplatelet therapy. [Internet] [Thesis]. Trinity College Dublin; 2020. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/2262/93211.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

SMITH DR. Profiles of von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in patients with ischaemic cerebrovascular disease after commencing or changing antiplatelet therapy. [Thesis]. Trinity College Dublin; 2020. Available from: http://hdl.handle.net/2262/93211

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

23. Schaeffer, Gilbert Van. Endothelial agonists stimulate VWF release in vitro and trigger TTP in vivo.

Degree: MS, Anatomy and Cell Biology, 2013, University of Iowa

  Von Willebrand factor (VWF) is a plasma glycoprotein that can bind collagen at a wound site as well as circulating platelets. VWF forms high… (more)

Subjects/Keywords: ADAMTS13; Endothelium; Strings; TTP; VWF; Cell Anatomy; Cell Biology

…These strings are rapidly cleaved in the presence of ADAMTS13, a VWF-cleaving plasma… …metalloprotease (2, 5, 8, 9). Deficiency in ADAMTS13 has been correlated with thrombotic… …thrombocytopenic Purpura (TTP) (9-14). ADAMTS13, which is primarily derived from… …Currently, no other substrates or functions for ADAMTS13 have been identified (2, 9, 12, 15… …16). Thrombotic Thrombocytopenic Purpura Severe ADAMTS13 deficiency in humans is… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Schaeffer, G. V. (2013). Endothelial agonists stimulate VWF release in vitro and trigger TTP in vivo. (Masters Thesis). University of Iowa. Retrieved from https://ir.uiowa.edu/etd/5054

Chicago Manual of Style (16th Edition):

Schaeffer, Gilbert Van. “Endothelial agonists stimulate VWF release in vitro and trigger TTP in vivo.” 2013. Masters Thesis, University of Iowa. Accessed December 05, 2020. https://ir.uiowa.edu/etd/5054.

MLA Handbook (7th Edition):

Schaeffer, Gilbert Van. “Endothelial agonists stimulate VWF release in vitro and trigger TTP in vivo.” 2013. Web. 05 Dec 2020.

Vancouver:

Schaeffer GV. Endothelial agonists stimulate VWF release in vitro and trigger TTP in vivo. [Internet] [Masters thesis]. University of Iowa; 2013. [cited 2020 Dec 05]. Available from: https://ir.uiowa.edu/etd/5054.

Council of Science Editors:

Schaeffer GV. Endothelial agonists stimulate VWF release in vitro and trigger TTP in vivo. [Masters Thesis]. University of Iowa; 2013. Available from: https://ir.uiowa.edu/etd/5054

24. Tjernberg, Anna Pernilla. The effect of mutated cysteine residues in von Willebrand factor.

Degree: 2007, Department of Hematology/ Thrombosis and Hemostasis, Medicine / Leiden University Medical Center (LUMC), Leiden University

 Von Willebrand factor (VWF) plays an important role in both primary and secondary hemostasis as a molecular glue between platelets and subendothelial structures, and as… (more)

Subjects/Keywords: ADAMTS13; Clearance; Coagulation; Cysteine; Dimerization; Multimerization; Von Willebrand factor; Von Willebrand disease; ADAMTS13; Clearance; Coagulation; Cysteine; Dimerization; Multimerization; Von Willebrand factor; Von Willebrand disease

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tjernberg, A. P. (2007). The effect of mutated cysteine residues in von Willebrand factor. (Doctoral Dissertation). Department of Hematology/ Thrombosis and Hemostasis, Medicine / Leiden University Medical Center (LUMC), Leiden University. Retrieved from http://hdl.handle.net/1887/12092

Chicago Manual of Style (16th Edition):

Tjernberg, Anna Pernilla. “The effect of mutated cysteine residues in von Willebrand factor.” 2007. Doctoral Dissertation, Department of Hematology/ Thrombosis and Hemostasis, Medicine / Leiden University Medical Center (LUMC), Leiden University. Accessed December 05, 2020. http://hdl.handle.net/1887/12092.

MLA Handbook (7th Edition):

Tjernberg, Anna Pernilla. “The effect of mutated cysteine residues in von Willebrand factor.” 2007. Web. 05 Dec 2020.

Vancouver:

Tjernberg AP. The effect of mutated cysteine residues in von Willebrand factor. [Internet] [Doctoral dissertation]. Department of Hematology/ Thrombosis and Hemostasis, Medicine / Leiden University Medical Center (LUMC), Leiden University; 2007. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/1887/12092.

Council of Science Editors:

Tjernberg AP. The effect of mutated cysteine residues in von Willebrand factor. [Doctoral Dissertation]. Department of Hematology/ Thrombosis and Hemostasis, Medicine / Leiden University Medical Center (LUMC), Leiden University; 2007. Available from: http://hdl.handle.net/1887/12092

25. 三浦, 光年; ミウラ, ミツトシ. 冠動脈疾患患者におけるvon Willebrand factor 切断酵素 (ADAMTS13)抗原値の予後予測因子としての役割 : カンドウミャク シッカン カンジャ ニ オケル von Willebrand factor セツダン コウソ ADAMTS13 コウゲンチ ノ ヨゴ ヨソク インシ ト シテ ノ ヤクワリ; Predictive value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in coronary artery disease patients.

Degree: Kumamoto University / 熊本大学

今回我々は安定冠動脈疾患患者における血漿ADAMTS13 抗原値を測定し、非冠動脈疾患患者との比較ならびに将来の心血管イベントとの関連を前向きに検討した。

Subjects/Keywords: VWF; ADAMTS13; 虚血性心疾患; 心房細動; 冠動脈疾患患者

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

三浦, 光年; ミウラ, . (n.d.). 冠動脈疾患患者におけるvon Willebrand factor 切断酵素 (ADAMTS13)抗原値の予後予測因子としての役割 : カンドウミャク シッカン カンジャ ニ オケル von Willebrand factor セツダン コウソ ADAMTS13 コウゲンチ ノ ヨゴ ヨソク インシ ト シテ ノ ヤクワリ; Predictive value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in coronary artery disease patients. (Thesis). Kumamoto University / 熊本大学. Retrieved from http://hdl.handle.net/2298/16571

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

三浦, 光年; ミウラ, ミツトシ. “冠動脈疾患患者におけるvon Willebrand factor 切断酵素 (ADAMTS13)抗原値の予後予測因子としての役割 : カンドウミャク シッカン カンジャ ニ オケル von Willebrand factor セツダン コウソ ADAMTS13 コウゲンチ ノ ヨゴ ヨソク インシ ト シテ ノ ヤクワリ; Predictive value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in coronary artery disease patients.” Thesis, Kumamoto University / 熊本大学. Accessed December 05, 2020. http://hdl.handle.net/2298/16571.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

三浦, 光年; ミウラ, ミツトシ. “冠動脈疾患患者におけるvon Willebrand factor 切断酵素 (ADAMTS13)抗原値の予後予測因子としての役割 : カンドウミャク シッカン カンジャ ニ オケル von Willebrand factor セツダン コウソ ADAMTS13 コウゲンチ ノ ヨゴ ヨソク インシ ト シテ ノ ヤクワリ; Predictive value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in coronary artery disease patients.” Web. 05 Dec 2020.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

三浦, 光年; ミウラ . 冠動脈疾患患者におけるvon Willebrand factor 切断酵素 (ADAMTS13)抗原値の予後予測因子としての役割 : カンドウミャク シッカン カンジャ ニ オケル von Willebrand factor セツダン コウソ ADAMTS13 コウゲンチ ノ ヨゴ ヨソク インシ ト シテ ノ ヤクワリ; Predictive value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in coronary artery disease patients. [Internet] [Thesis]. Kumamoto University / 熊本大学; [cited 2020 Dec 05]. Available from: http://hdl.handle.net/2298/16571.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

三浦, 光年; ミウラ . 冠動脈疾患患者におけるvon Willebrand factor 切断酵素 (ADAMTS13)抗原値の予後予測因子としての役割 : カンドウミャク シッカン カンジャ ニ オケル von Willebrand factor セツダン コウソ ADAMTS13 コウゲンチ ノ ヨゴ ヨソク インシ ト シテ ノ ヤクワリ; Predictive value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in coronary artery disease patients. [Thesis]. Kumamoto University / 熊本大学; Available from: http://hdl.handle.net/2298/16571

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

26. Fujioka, Masayuki; Nakano, Takafumi; Hayakawa, Kazuhide; Irie, Keiichi; Akitake, Yoshiharu; Sakamoto, Yuya; Mishima, Kenichi; Muroi, Carl; Yonekawa, Yasuhiro; Banno, Fumiaki; Kokame, Koichi; Miyata, Toshiyuki; Nishio, Kenji; Okuchi, Kazuo; Iwasaki, Katsunori; Fujiwara, Michihiro. ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury. : ADAMTS13 遺伝子欠損は脳虚血再灌流傷害における血漿high mobility group box1 の上昇を促進し神経炎症を悪化させる。.

Degree: Nara Medical University / 奈良県立医科大学

Highly adhesive glycoprotein von Willebrand factor (VWF) multimer induces platelet aggregation and leukocyte tethering or extravasation on the injured vascular wall, contributing to microvascular plugging… (more)

Subjects/Keywords: Brain ischemia–reperfusion; High-mobility group box1; ADAMTS13; Inflammation; Von Willebrand factor; Thrombotic thrombocytopenic purpura

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fujioka, Masayuki; Nakano, Takafumi; Hayakawa, Kazuhide; Irie, Keiichi; Akitake, Yoshiharu; Sakamoto, Yuya; Mishima, Kenichi; Muroi, Carl; Yonekawa, Yasuhiro; Banno, Fumiaki; Kokame, Koichi; Miyata, Toshiyuki; Nishio, Kenji; Okuchi, Kazuo; Iwasaki, Katsunori; Fujiwara, M. (n.d.). ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury. : ADAMTS13 遺伝子欠損は脳虚血再灌流傷害における血漿high mobility group box1 の上昇を促進し神経炎症を悪化させる。. (Thesis). Nara Medical University / 奈良県立医科大学. Retrieved from http://hdl.handle.net/10564/2790

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Fujioka, Masayuki; Nakano, Takafumi; Hayakawa, Kazuhide; Irie, Keiichi; Akitake, Yoshiharu; Sakamoto, Yuya; Mishima, Kenichi; Muroi, Carl; Yonekawa, Yasuhiro; Banno, Fumiaki; Kokame, Koichi; Miyata, Toshiyuki; Nishio, Kenji; Okuchi, Kazuo; Iwasaki, Katsunori; Fujiwara, Michihiro. “ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury. : ADAMTS13 遺伝子欠損は脳虚血再灌流傷害における血漿high mobility group box1 の上昇を促進し神経炎症を悪化させる。.” Thesis, Nara Medical University / 奈良県立医科大学. Accessed December 05, 2020. http://hdl.handle.net/10564/2790.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Fujioka, Masayuki; Nakano, Takafumi; Hayakawa, Kazuhide; Irie, Keiichi; Akitake, Yoshiharu; Sakamoto, Yuya; Mishima, Kenichi; Muroi, Carl; Yonekawa, Yasuhiro; Banno, Fumiaki; Kokame, Koichi; Miyata, Toshiyuki; Nishio, Kenji; Okuchi, Kazuo; Iwasaki, Katsunori; Fujiwara, Michihiro. “ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury. : ADAMTS13 遺伝子欠損は脳虚血再灌流傷害における血漿high mobility group box1 の上昇を促進し神経炎症を悪化させる。.” Web. 05 Dec 2020.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Fujioka, Masayuki; Nakano, Takafumi; Hayakawa, Kazuhide; Irie, Keiichi; Akitake, Yoshiharu; Sakamoto, Yuya; Mishima, Kenichi; Muroi, Carl; Yonekawa, Yasuhiro; Banno, Fumiaki; Kokame, Koichi; Miyata, Toshiyuki; Nishio, Kenji; Okuchi, Kazuo; Iwasaki, Katsunori; Fujiwara M. ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury. : ADAMTS13 遺伝子欠損は脳虚血再灌流傷害における血漿high mobility group box1 の上昇を促進し神経炎症を悪化させる。. [Internet] [Thesis]. Nara Medical University / 奈良県立医科大学; [cited 2020 Dec 05]. Available from: http://hdl.handle.net/10564/2790.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Fujioka, Masayuki; Nakano, Takafumi; Hayakawa, Kazuhide; Irie, Keiichi; Akitake, Yoshiharu; Sakamoto, Yuya; Mishima, Kenichi; Muroi, Carl; Yonekawa, Yasuhiro; Banno, Fumiaki; Kokame, Koichi; Miyata, Toshiyuki; Nishio, Kenji; Okuchi, Kazuo; Iwasaki, Katsunori; Fujiwara M. ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury. : ADAMTS13 遺伝子欠損は脳虚血再灌流傷害における血漿high mobility group box1 の上昇を促進し神経炎症を悪化させる。. [Thesis]. Nara Medical University / 奈良県立医科大学; Available from: http://hdl.handle.net/10564/2790

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

27. Hulstein, J.J.J. Active Von Willebrand Factor, thrombocytopenia and thrombosis.

Degree: 2006, University Utrecht

 Platelets and von Willebrand factor (VWF) are unable to interact in circulation. To induce an interaction, a conversion of VWF to a platelet-binding conformation is… (more)

Subjects/Keywords: Von Willebrand Factor; ADAMTS13; beta2-glycoprotein I; Von Willebrand Disease; Thrombotic Thrombocytopenic Purpura; HELLP syndrome; antiphospholipid syndrome; thrombocytopenia; thrombosis; thrombotic microangiopathy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hulstein, J. J. J. (2006). Active Von Willebrand Factor, thrombocytopenia and thrombosis. (Doctoral Dissertation). University Utrecht. Retrieved from https://dspace.library.uu.nl/handle/1874/18678 ; URN:NBN:NL:UI:10-1874-18678 ; urn:isbn:90-393-4405-1 ; URN:NBN:NL:UI:10-1874-18678 ; https://dspace.library.uu.nl/handle/1874/18678

Chicago Manual of Style (16th Edition):

Hulstein, J J J. “Active Von Willebrand Factor, thrombocytopenia and thrombosis.” 2006. Doctoral Dissertation, University Utrecht. Accessed December 05, 2020. https://dspace.library.uu.nl/handle/1874/18678 ; URN:NBN:NL:UI:10-1874-18678 ; urn:isbn:90-393-4405-1 ; URN:NBN:NL:UI:10-1874-18678 ; https://dspace.library.uu.nl/handle/1874/18678.

MLA Handbook (7th Edition):

Hulstein, J J J. “Active Von Willebrand Factor, thrombocytopenia and thrombosis.” 2006. Web. 05 Dec 2020.

Vancouver:

Hulstein JJJ. Active Von Willebrand Factor, thrombocytopenia and thrombosis. [Internet] [Doctoral dissertation]. University Utrecht; 2006. [cited 2020 Dec 05]. Available from: https://dspace.library.uu.nl/handle/1874/18678 ; URN:NBN:NL:UI:10-1874-18678 ; urn:isbn:90-393-4405-1 ; URN:NBN:NL:UI:10-1874-18678 ; https://dspace.library.uu.nl/handle/1874/18678.

Council of Science Editors:

Hulstein JJJ. Active Von Willebrand Factor, thrombocytopenia and thrombosis. [Doctoral Dissertation]. University Utrecht; 2006. Available from: https://dspace.library.uu.nl/handle/1874/18678 ; URN:NBN:NL:UI:10-1874-18678 ; urn:isbn:90-393-4405-1 ; URN:NBN:NL:UI:10-1874-18678 ; https://dspace.library.uu.nl/handle/1874/18678

28. Pos, W. Characterization of human antibodies against ADAMTS13 that develop in patients with acquired TTP.

Degree: 2010, University Utrecht

 Thrombotic thrombocytopenic purpura (TTP) is a thrombotic micro-angiopathy characterized by the absence or dysfunction of the von Willebrand factor cleaving protease ADAMTS13. Functional absence of… (more)

Subjects/Keywords: Medical technology; Farmacie(FARM); Biomedische technologie en medicijnen; Pharmacology; autoantibodies; ADAMTS13; epitope; TTP; VWF

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pos, W. (2010). Characterization of human antibodies against ADAMTS13 that develop in patients with acquired TTP. (Doctoral Dissertation). University Utrecht. Retrieved from https://dspace.library.uu.nl/handle/1874/183095 ; URN:NBN:NL:UI:10-1874-183095 ; urn:isbn:978-90-393-5410-0 ; URN:NBN:NL:UI:10-1874-183095 ; https://dspace.library.uu.nl/handle/1874/183095

Chicago Manual of Style (16th Edition):

Pos, W. “Characterization of human antibodies against ADAMTS13 that develop in patients with acquired TTP.” 2010. Doctoral Dissertation, University Utrecht. Accessed December 05, 2020. https://dspace.library.uu.nl/handle/1874/183095 ; URN:NBN:NL:UI:10-1874-183095 ; urn:isbn:978-90-393-5410-0 ; URN:NBN:NL:UI:10-1874-183095 ; https://dspace.library.uu.nl/handle/1874/183095.

MLA Handbook (7th Edition):

Pos, W. “Characterization of human antibodies against ADAMTS13 that develop in patients with acquired TTP.” 2010. Web. 05 Dec 2020.

Vancouver:

Pos W. Characterization of human antibodies against ADAMTS13 that develop in patients with acquired TTP. [Internet] [Doctoral dissertation]. University Utrecht; 2010. [cited 2020 Dec 05]. Available from: https://dspace.library.uu.nl/handle/1874/183095 ; URN:NBN:NL:UI:10-1874-183095 ; urn:isbn:978-90-393-5410-0 ; URN:NBN:NL:UI:10-1874-183095 ; https://dspace.library.uu.nl/handle/1874/183095.

Council of Science Editors:

Pos W. Characterization of human antibodies against ADAMTS13 that develop in patients with acquired TTP. [Doctoral Dissertation]. University Utrecht; 2010. Available from: https://dspace.library.uu.nl/handle/1874/183095 ; URN:NBN:NL:UI:10-1874-183095 ; urn:isbn:978-90-393-5410-0 ; URN:NBN:NL:UI:10-1874-183095 ; https://dspace.library.uu.nl/handle/1874/183095

29. Hulstein, J.J.J. Active Von Willebrand Factor, thrombocytopenia and thrombosis.

Degree: 2006, University Utrecht

 Platelets and von Willebrand factor (VWF) are unable to interact in circulation. To induce an interaction, a conversion of VWF to a platelet-binding conformation is… (more)

Subjects/Keywords: Von Willebrand Factor; ADAMTS13; beta2-glycoprotein I; Von Willebrand Disease; Thrombotic Thrombocytopenic Purpura; HELLP syndrome; antiphospholipid syndrome; thrombocytopenia; thrombosis; thrombotic microangiopathy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hulstein, J. J. J. (2006). Active Von Willebrand Factor, thrombocytopenia and thrombosis. (Doctoral Dissertation). University Utrecht. Retrieved from https://dspace.library.uu.nl/handle/1874/18678 ; URN:NBN:NL:UI:10-1874-18678 ; urn:isbn:90-393-4405-1 ; URN:NBN:NL:UI:10-1874-18678 ; https://dspace.library.uu.nl/handle/1874/18678

Chicago Manual of Style (16th Edition):

Hulstein, J J J. “Active Von Willebrand Factor, thrombocytopenia and thrombosis.” 2006. Doctoral Dissertation, University Utrecht. Accessed December 05, 2020. https://dspace.library.uu.nl/handle/1874/18678 ; URN:NBN:NL:UI:10-1874-18678 ; urn:isbn:90-393-4405-1 ; URN:NBN:NL:UI:10-1874-18678 ; https://dspace.library.uu.nl/handle/1874/18678.

MLA Handbook (7th Edition):

Hulstein, J J J. “Active Von Willebrand Factor, thrombocytopenia and thrombosis.” 2006. Web. 05 Dec 2020.

Vancouver:

Hulstein JJJ. Active Von Willebrand Factor, thrombocytopenia and thrombosis. [Internet] [Doctoral dissertation]. University Utrecht; 2006. [cited 2020 Dec 05]. Available from: https://dspace.library.uu.nl/handle/1874/18678 ; URN:NBN:NL:UI:10-1874-18678 ; urn:isbn:90-393-4405-1 ; URN:NBN:NL:UI:10-1874-18678 ; https://dspace.library.uu.nl/handle/1874/18678.

Council of Science Editors:

Hulstein JJJ. Active Von Willebrand Factor, thrombocytopenia and thrombosis. [Doctoral Dissertation]. University Utrecht; 2006. Available from: https://dspace.library.uu.nl/handle/1874/18678 ; URN:NBN:NL:UI:10-1874-18678 ; urn:isbn:90-393-4405-1 ; URN:NBN:NL:UI:10-1874-18678 ; https://dspace.library.uu.nl/handle/1874/18678

30. Bongers, Tamara. ADAMTS13 in arterial thrombosis.

Degree: 2010, Erasmus University Medical Center

 textabstractThe aim of this thesis was to study the role of ADAMTS13 in arterial thrombosis, a disease that comprises both environmental and genetic factors. We… (more)

Subjects/Keywords: ADAMTS13; VWF; arterial thrombosis; cardiovascular disease; ischemic stroke; liver cirrhosis; myocardial infarction; peripheral arterial disease; sepsis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bongers, T. (2010). ADAMTS13 in arterial thrombosis. (Doctoral Dissertation). Erasmus University Medical Center. Retrieved from http://hdl.handle.net/1765/21819

Chicago Manual of Style (16th Edition):

Bongers, Tamara. “ADAMTS13 in arterial thrombosis.” 2010. Doctoral Dissertation, Erasmus University Medical Center. Accessed December 05, 2020. http://hdl.handle.net/1765/21819.

MLA Handbook (7th Edition):

Bongers, Tamara. “ADAMTS13 in arterial thrombosis.” 2010. Web. 05 Dec 2020.

Vancouver:

Bongers T. ADAMTS13 in arterial thrombosis. [Internet] [Doctoral dissertation]. Erasmus University Medical Center; 2010. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/1765/21819.

Council of Science Editors:

Bongers T. ADAMTS13 in arterial thrombosis. [Doctoral Dissertation]. Erasmus University Medical Center; 2010. Available from: http://hdl.handle.net/1765/21819

[1] [2]

.